ArticleEnvironment & health (Washington, D.C.)2026
Concentration-Specific Neurotoxic Pathways of Tetrabromobisphenol A and Tetrabromobisphenol A Bis(2-Hydroxyethyl Ether) in Zebrafish Larvae.
Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tetrabromobisphenol A (TBBPA) and its derivative, TBBPA bis-(2-hydroxyethyl ether) (TBBPA-BHEE), are widely used brominated flame retardants commonly detected in environmental media and biota. While regulatory bodies deem these chemicals unlikely to pose significant risks, emerging evidence highlights their potential neurotoxic effects. In this study, we evaluated the neurodevelopmental toxicity of TBBPA and TBBPA-BHEE in zebrafish embryos exposed to nonlethal (94-470 μg/L for TBBPA, 610-2030 μg/L for TBBPA-BHEE) and environmentally relevant concentrations (0.094-0.47 μg/L for TBBPA, 0.061-0.203 μg/L for TBBPA-BHEE) for up to 120 h postfertilization (hpf). Our findings show that at nonlethal concentrations, both TBBPA and TBBPA-BHEE impaired craniofacial development, induced apoptosis, reduced γ-aminobutyric acid (GABA) levels, and disrupted motor behavior, with significant alterations in the expression of genes involved in GABAergic signaling and synaptic plasticity. Transcriptomic and miRNA profiling revealed that downregulation of GABA receptor genes and miRNAs (e.g., let-7i, miR-192,) contributed to neurodevelopmental defects through disruption of CREB signaling and synaptogenesis. In contrast, exposure to environmentally relevant concentrations induced similar phenotypes (craniofacial malformations and apoptosis) without major changes in neurotransmitter levels, suggesting that low-dose neurotoxicity might be mediated by alternative, less understood mechanisms, possibly involving epigenetic modifications or compensatory neuronal adaptations. These findings underscore the complexity of low-dose toxicity and the need for further research into the molecular pathways underlying the neurotoxic effects of TBBPA and its derivatives, particularly at environmentally relevant concentrations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.